You are here: Industry Insights > antibody

News List

FDA grants emergency use authorisation to COVID-19 antibody bamlanivimab europeanpharmaceuticalreview
November 13, 2020
The neutralising antibody therapy bamlanivimab (LY-CoV555) is authorised for emergency use in recently diagnosed patients who are at risk of developing severe COVID-19.
Llama nanobodies could be a powerful weapon against COVID-19 worldpharmanews
November 10, 2020
The researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to ...
Feinstein Institutes gets $11.3 million subcontract for COVID-19 antibody research expresspharma
November 06, 2020
Researchers to develop and deploy serological (antibody) testing assays as well as study the molecular mechanisms driving serological, humoral, and cellular immune responses to the virus.
Truvian to Make Rapid Antibody Testing More Accessible with Easy Check COVID-19 IgM/IgG™ POC Antibody Test americanpharmaceuticalreview
November 02, 2020
Truvian Sciences announced its submission of the Easy Check COVID-19 IgM/IgG™ Point-of-Care (POC) Antibody Test to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA).
Study finds novel COVID-19 antibody therapy may reduce hospitalisations expresspharma
November 02, 2020
The antibody slows down the replication process, allowing the patient's own immune system time to kick into gear.
UK biotech consortium identifies COVID-19 antibody combinations pharmatimes
October 30, 2020
The UK BIA Antibody Taskforce, a UK consortium developing antibodies for treating COVID-19, has identified differentiated antibody combinations to take further into development as as an antibody cocktail.
CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate prnasia
October 29, 2020
CStone Pharmaceuticals announced today a licensing agreement with LegoChem Biosciences, Inc., for the development and commercialization of LCB71, a potential first-in-class/best-in-class antibody drug conjugate ("ADC").
Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData expresspharma
October 29, 2020
Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael Breen, Director of Infectious Diseases and Ophthalmology at GlobalData offers his view.
Cipla launches ELIFast for COVID-19 antibody detection expresspharma
October 29, 2020
Cipla announced the commercialisation of antibody detection kits for COVID-19 in India. It is in partnership with KARWA under the technology transfer from the Indian Council of Medical Research (ICMR).
SARS-CoV-2 vaccine safely induces an immune response in healthy volunteers europeanpharmaceuticalreview
October 22, 2020
The Chinese COVID-19 vaccine candidate BBIBP-CorV elicited an antibody response in all recipients, according to preliminary Phase I/II trial data.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page